Next-generation sequencing identifies subtypes that may benefit from immune checkpoint inhibitors.
Miguel Gonzalez-Velez, MD
Advertisement
Articles by Miguel Gonzalez-Velez, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of neuromodulation therapy for erectile dysfunction after radical prostatectomy
2
Andrea B. Apolo, MD, discusses survival gains with EV/pembrolizumab in bladder cancer
3
Rectal diazepam eases instillation of nadofaragene firadenovec in NMIBC
4
Published data show benefit of niraparib with AAP in HRR-deficient mCSPC
5
